Infant mortality and life expectancy in China.
Yanhua Xu1, Weifang Zhang1, Rulai Yang1
1Department of Newborn Screening, Children's Hospital of Zhejiang University School of Medicine, Hangzhou, China (mainland).
Summary
China achieved rapid declines in infant mortality (IM) and increases in life expectancy (LE), but these health gains are not fully aligned with economic development. Further investigation into infant deaths is recommended.
Area of Science:
- Public Health
- Demography
- Health Economics
Background:
- China has experienced significant reductions in infant mortality (IM) and increases in life expectancy (LE).
- Understanding the current health status and the interplay between IM and LE is crucial for public health policy.
Purpose of the Study:
- To investigate the health status of the Chinese population by examining infant mortality (IM) and life expectancy (LE).
- To determine the inter-relationship between IM, LE, and per capita gross national income (GNI).
Main Methods:
- A literature review was conducted on the history and current status of IM and LE in China and other major countries.
- The relationship between IM, LE, and per capita GNI was analyzed for the year 2013.
Main Results:
- China's IM decline (30% to 15% in 7 years) surpassed that of developed nations.
- Leading infant death causes include perinatal diseases, infections, congenital anomalies, and accidents.
- Life expectancy (LE) showed strong negative correlations with IM (r=-0.921) and per capita GNI (r=0.778).
- Infant mortality (IM) was negatively correlated with per capita GNI (r=-0.735).
- China's healthcare capabilities and per capita GNI remain below developing country levels, despite comparable IM and healthcare metrics in some nations with higher GNIs.
Conclusions:
- While IM has decreased and LE increased rapidly in China, these trends are not parallel with economic development.
- Discrepancies may stem from various factors, necessitating further in-house surveys and hospital-based follow-ups to understand infant mortality causes.
Related Concept Videos
Life Tables
674
A life table is a statistical tool that summarizes the mortality and survival patterns of a population, providing detailed insights into the likelihood of survival or death across different age intervals within a cohort. By organizing data on survival probabilities and mortality rates, life tables offer a clear snapshot of population dynamics over time. They are extensively used in demography, public health, actuarial science, and ecology to analyze life expectancy, design health interventions,...
674
Applications of Life Tables
429
Life tables are versatile across various fields, providing a quantitative basis for analyzing mortality and survival rates. Whether used by demographers, actuaries, epidemiologists, or sociologists, life tables offer valuable insights into the dynamics of life and death, facilitating informed decisions in public health, insurance, conservation, and beyond. Their broad applicability highlights the interconnectedness of demographic data with practical outcomes in everyday life and strategic...
429
Life Histories
16.3K
Overview
16.3K
Actuarial Approach
384
The actuarial approach, a statistical method originally developed for life insurance risk assessment, is widely used to calculate survival rates in clinical and population studies. This method accounts for participants lost to follow-up or those who die from causes unrelated to the study, ensuring a more accurate representation of survival probabilities.
Consider the example of a high-risk surgical procedure with significant early-stage mortality. A two-year clinical study is conducted,...
Consider the example of a high-risk surgical procedure with significant early-stage mortality. A two-year clinical study is conducted,...
384
Pharmacokinetics in Pediatric Patients: Drug Distribution
554
Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
554
Cancer Survival Analysis
863
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
863

